Discovery of VX-509(Decernotinib): A Potent and SelectiveJanus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases.

Autor: Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock, MichaelJ. Arnost, Randy S. Bethiel, Youssef L. Bennani, James J. Black, Christopher L. Brummel, Ananthsrinivas Chakilam, Warren A. Dorsch, Bin Fan, JohnE. Cochran, Summer Halas, Edmund M. Harrington, JamesK. Hogan, David Howe, Hui Huang, DylanH. Jacobs, Leena M. Laitinen, Shengkai Liao
Zdroj: Journal of Medicinal Chemistry; Sep2015, Vol. 58 Issue 18, p7195-7216, 22p
Databáze: Supplemental Index